FibroGen
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,348 | $2,739 | $-123,256 | $46,333 |
Gross Profit | 1,263 | 2,487 | -102,590 | 41,038 |
EBITDA | -11,545 | -14,180 | -91,100 | -12,237 |
EBIT | -11,766 | -14,507 | -91,452 | -12,976 |
Net Income | -7,603 | 4,639 | 17,982 | -17,084 |
Net Change In Cash | 1,348 | 2,739 | -123,256 | 46,333 |
Free Cash Flow | 12,669 | 2,703 | -30,607 | -8,458 |
Cash | 23,367 | 33,609 | 50,482 | 131,003 |
Basic Shares | 4,042 | 100,954 | 100,830 | 100,515 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $29,621 | $46,803 | $140,734 | $235,309 |
Gross Profit | 14,060 | 42,841 | 120,454 | 222,438 |
EBITDA | -142,428 | -305,197 | -282,825 | -273,721 |
EBIT | -145,120 | -315,127 | -293,429 | -288,530 |
Net Income | -47,579 | -284,232 | -293,654 | -291,030 |
Net Change In Cash | 29,621 | 46,803 | 140,734 | 235,309 |
Cost of Revenue | -509,767 | |||
Free Cash Flow | -138,265 | -317,540 | -184,674 | -112,418 |
Cash | 50,482 | 113,688 | 155,700 | 171,223 |
Basic Shares | 100,044 | 97,303 | 93,582 | 92,349 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.88 |
2025-03-31 | $0.05 |
2024-12-31 | -$0.08 |
2024-09-30 | $0.01 |
